VTRNA1-3: Key Regulator of Cell Proliferation and Signaling Pathways
VTRNA1-3: Key Regulator of Cell Proliferation and Signaling Pathways
VTRNA1-3 (Vaultin-伪-1 subunit nicking RNA-protein 3) is a protein that is expressed in various tissues of the human body, including the brain, heart, and gastrointestinal tract. It is a key regulator of cell proliferation and has has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
One of the unique features of VTRNA1-3 is its ability to nicking other proteins, including RNA-protein 2 (RPN2), a protein that is involved in the regulation of RNA stability and quality control. This nicking ability is critical for VTRNA1-3's function as it allows the protein to regulate the activity of other proteins and to control the levels of certain proteins in the cell.
VTRNA1-3 is a member of the Vaultin family of proteins, which are involved in the regulation of various cellular processes, including cell adhesion, migration, and the transport of vesicles and organelles. The Vaultin family has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
In addition to its role in regulating the activity of other proteins, VTRNA1-3 has also been shown to play a role in the regulation of gene expression. Studies have shown that VTRNA1-3 can interact with certain genes and can alter their activity, including the expression of genes involved in cell adhesion, migration, and the regulation of the blood-brain barrier.
VTRNA1-3 has also been shown to play a role in the regulation of cellular signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.
In conclusion, VTRNA1-3 is a protein that has important roles in the regulation of cell proliferation and signaling pathways. Its unique ability to nick other proteins, including RNA-protein 2, makes it a potential drug target and may be a useful biomarker for the diagnosis and treatment of various diseases. Further research is needed to fully understand the functions of VTRNA1-3 and its potential as a drug.
Protein Name: Vault RNA 1-3
The "VTRNA1-3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VTRNA1-3 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
VTRNA2-1 | VTRNA3-1P | VWA1 | VWA2 | VWA3A | VWA3B | VWA5A | VWA5B1 | VWA5B2 | VWA7 | VWA8 | VWC2 | VWC2L | VWCE | VWDE | VWF | VXN | WAC | WAC-AS1 | WAKMAR1 | WAKMAR2 | WAPL | WARS1 | WARS2 | WARS2-AS1 | WAS | WASF1 | WASF2 | WASF3 | WASF4P | WASF5P | WASH complex | WASH2P | WASH3P | WASH4P | WASH5P | WASH6P | WASH7P | WASH8P | WASHC1 | WASHC2A | WASHC2C | WASHC3 | WASHC4 | WASHC5 | WASIR1 | WASL | WAVE1 complex | WBP1 | WBP11 | WBP11P1 | WBP1L | WBP2 | WBP2NL | WBP4 | WDCP | WDFY1 | WDFY2 | WDFY3 | WDFY3-AS2 | WDFY4 | WDHD1 | WDPCP | WDR1 | WDR11 | WDR11-DT | WDR12 | WDR13 | WDR17 | WDR18 | WDR19 | WDR20 | WDR24 | WDR25 | WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B
